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Background: Tradeoffs among competing traits are believed to be crucial to the maintenance of diversity in
complex communities. The production of antibiotics to inhibit competitors and resistance to antibiotic inhibition
are two traits hypothesized to be critical to microbial fitness in natural habitats, yet data on costs or tradeoffs
associated with these traits are limited. In this work we characterized tradeoffs between antibiotic inhibition or
resistance capacities and growth efficiencies or niche widths for a broad collection of Streptomyces from soil.
Results: Streptomyces isolates tended to have either very little or very high inhibitory capacity. In contrast,
Streptomyces isolates were most commonly resistant to antibiotic inhibition by an intermediate number of other
isolates. Streptomyces with either very high antibiotic inhibitory or resistance capacities had less efficient growth and
utilized a smaller number of resources for growth (smaller niche width) than those with low inhibition or resistance
capacities, suggesting tradeoffs between antibiotic inhibitory or resistance and resource use phenotypes.
Conclusions: This work suggests that life-history tradeoffs may be crucial to the maintenance of the vast diversity
of antibiotic inhibitory and resistance phenotypes found among Streptomyces in natural communities.Background
Soil bacteria produce an astounding array of antimicro-
bial compounds [1] Antibiotic production is believed to
provide a fitness benefit to the producer by inhibiting
the growth of competing microbes [2–5]. In response,
competitors may overcome inhibition by acquiring re-
sistance to antibiotics through mutations or horizontal
gene transfer [6, 7]. Antibiotic inhibition and resistance
phenotypes are extremely diverse in natural habitats and
highly variable among soil bacteria [4, 8]. However, how
this diversity is maintained in soil microbial communi-
ties is not well understood. In particular, what limits the
accumulation of antibiotic production and resistance
genes among bacterial populations in soil?
Tradeoffs preclude an organism’s ability to optimize
multiple traits [9, 10]. It is commonly assumed that be-
cause antibiotic production and resistance generally re-
quire energy expenditure they are accompanied by
tradeoffs with growth or other fitness components. As a* Correspondence: kinkel@umn.edu
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pected to be out-competed by non-producing counter-
parts in the absence of susceptible competitors [11–13].
Similarly, microbes that carry resistance to antibiotics
are expected to be out-competed by susceptible counter-
parts in the absence of antibiotic-producing competitors
[11, 13, 14]. Although tradeoffs between growth and
antibiotic resistance have been studied in clinical settings
[14], the lack of analogous data for antibiotic production
or resistance among naturally-occurring microbial popu-
lations limits our understanding of the dynamics of anti-
biotic inhibition and resistance within soil communities.
Tradeoffs associated with antibiotic production and re-
sistance should be reflected in growth reductions for
antibiotic-producing vs. non-producing bacteria in the
absence of competition (ie. physiological tradeoffs; [12])
or, more generally, in negative relationships among dis-
tinct phenotypic traits (ie. life history tradeoffs; [9]).
Since bacterial strains often produce and resist many an-
tibiotics in tandem [15–17], tradeoffs that are important
for the fitness of individuals are likely to encompass the
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biotic compounds is likely to require a greater total allo-
cation of resources compared to production of a single
antibiotic, whereas the costs of multiple resistances may
depend on the specific resistance mechanisms (eg. multi-
drug efflux pumps versus the accumulation of resistance
mutations). At the same time, it has been hypothesized
that the accumulation of antibiotic production and resist-
ance among bacteria is driven by a coevolutionary arms
race [13, 15]. Arms race dynamics are hypothesized to re-
sult in extreme traits in populations [18]. For example,
among microbial pathogen populations, arms race coevo-
lution is considered to be responsible for the accumula-
tion of virulence and resistance [19–21], and may also
generate a preponderance of bacteria with highly antagon-
istic or resistant phenotypes [13]. However, there are few
data on the distribution of cumulative antibiotic inhibition
and resistance phenotypes among soil bacteria, and evi-
dence for significant fitness tradeoffs associated with anti-
biotic inhibitory or resistance phenotypes is limited.
Streptomyces are filamentous, Gram-positive bacteria
that are prolific producers of antibiotics and a significant
reservoir of antibiotic resistance in soils [16, 17]. Anti-
biotic production by Streptomyces is often dependent on
resource availability [22–24]. Moreover, Streptomyces vary
extensively in the resources on which they can grow and
in their relative growth efficiencies on different resources
[25], suggesting the potential for diverse competitive strat-
egies. Fitness tradeoffs associated with antibiotic inhibition
or resistance may limit the evolution of Streptomyces that
are both highly antagonistic and growth efficient on a
wide array of resources. However, specific data on the re-
lationships among Streptomyces resource use, antibiotic
inhibition, and antibiotic resistance from natural settings
are needed to understand the potential for fitness tradeoffs
to constrain the accumulation of antibiotic inhibition or
resistance capacities in soil microbes.
In this work we hypothesize that there are life-history
tradeoffs associated with the antibiotic inhibitory and re-
sistance capacities of Streptomyces within natural soil
populations. We examine patterns of antibiotic inhib-
ition and resistance phenotypes among n = 263 Strepto-
myces isolates from natural soil settings in relation to
their resource use on 95 sole carbon sources. Specific-
ally, we 1) characterize antibiotic inhibition and resist-
ance among Streptomyces and quantify inhibition and
resistance phenotypes among isolates; 2) determine rela-
tionships between antibiotic inhibition, resistance, and
resource use among Streptomyces isolates; and 3) explore
evidence for tradeoffs among Streptomyces exhibiting
distinct inhibition and resistance strategies. These data
suggest that tradeoffs may be critical in structuring anti-
biotic production and resistance strategies among Strep-
tomyces in soil.Methods
Soil sampling, processing, and isolation
Soil samples were collected at the University of Minnesota
Cedar Creek Ecosystem Science Reserve (www.cedarcree-
k.umn.edu), a NSF Long-Term Ecological Research site as
described previously [4]. Three soil cores were taken from
random locations within 1 m2 sections of two plots in ex-
periment E001 (plots 08-A and 10-D) for a total of six soil
cores. Soil cores were transported to the lab on ice and
processed immediately. Soils were dried overnight under a
double-layer of sterile cheesecloth, serially diluted in phos-
phate buffer (0.5 M K2HPO4, 0.4 M KH2PO4, pH = 7.0),
and plated on oatmeal agar as described in Davelos et al.
[4]. Plates were incubated at 28 C for 7 days and Strepto-
myces densities were estimated based on characteristic
colony morphology. Streptomyces colonies were randomly
picked with a sterile toothpick, purified, and stored in
20 % glycerol at -80 C for further study. Detailed informa-
tion on soil collection, processing, and isolation is pub-
lished elsewhere [4].
Characterization of Streptomyces antibiotic inhibition and
resistance
Streptomyces antibiotic inhibition and resistance profiles
were determined against ten standard reference isolates
described in Davelos et al. [26] Standard strains encom-
pass genotypically and phenotypically diverse isolates
collected from multiple locations in Minnesota. More-
over, these test stains differ in their antibiotic inhibition
and resistance profiles so that they can differentiate up
to 1024 different inhibition and resistance phenotypes in
pair-wise assays [26]. Because Streptomyces inhibitory
phenotypes may be adapted to inhibit local resource
competitors at small spatial scales (within 1 m2; [5]) and
isolates were collected from multiple different locations,
standard test isolates provide an assessment of Strepto-
myces antibiotic inhibitory and resistance phenotypes
that is independent from the location of origin of the
tested isolates. Streptomyces isolates (n = 263) were char-
acterized for antibiotic inhibition profiles by evaluating
their ability to inhibit each standard isolate using an
agar-overlay method [4]. Briefly, 10 ul of spore suspen-
sions (~108 spores/ml) were dotted onto 15 ml starch-
casein agar (SCA). After incubation for 3 days at 28 C,
isolates were killed by inverting each plate over a watch
glass containing 4 ml chloroform. Plates were then left
open in a laminar flow hood for 30 min to allow residual
chloroform to evaporate, then overlaid with 15 ml of
fresh 1 % water agar. After the agar solidified 100 ul of
each test standard spore stock (~108 spores/ml) was
spread on the plate. Plates were incubated for 3 days at
28 C and the size of inhibition zones around dotted iso-
lates were measured. Each Streptomyces-standard inter-
action was replicated three times and only inhibition
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tory. The same approach was used to characterize the
collection of Streptomyces isolates for resistance to anti-
biotic inhibition by each standard isolate. Spatial vari-
ation in the inhibition and resistance characteristics of a
subset of the isolates used in this work have been pub-
lished previously [4], though their relationships with re-
source use have not been explored previously.
Resource use
Resource use was evaluated on Biolog SF-P2 microplates
(Biolog, Inc. Hayward, CA) using standard procedures as
described in Schlatter et al. [25]. Measurement of growth
in Biolog SF-P2 plates rely on the turbidity of each well
(absorbance) as a measure of microbial growth, rather
than a redox dye. Thus, growth measurements in Biolog
SF-P2 plates offer a rapid and standardized means to
quantify the cumulative reproductive output of Strepto-
myces isolates on a diverse array of sole carbon sources.
Fresh spore suspensions of each Streptomyces isolate
were quantified to an absorbance of 0.22 at 590 nm, di-
luted according to the manufacturer’s instructions, and
inoculated into Biolog SF-P2 plates. Plates were incu-
bated at 28 C for 3 days and the absorbance of each well
was measured (590 nm). The absorbance (au) from the
water control well was subtracted from all 95 substrate-
containing wells. After correction, all wells with an ab-
sorbance <0.005 were adjusted to 0 prior to analyses.
We defined niche width as the number of substrates on
which an isolate could grow (positive absorbance after
adjustments). Growth efficiency was defined as the
mean growth on used substrates (mean of absorbance
values >0). Variation in resource use of these isolates
has been explored [25], yet their relationships with
inhibition or resistance traits have not been previously
evaluated.
Statistical analyses
All statistical analyses were performed in the R statistical
package (Version 3.0.2, [27]) or GraphPad Prism (Ver-
sion 6; GraphPad Software, La Jolla California, USA).
Spearman correlations and linear regression were used
to test for relationships between Streptomyces inhibitory,
resistance, and resource use phenotypes. Permutation
tests (n = 10,000 permutations) were used for Spearman
correlations to estimate the significance of relationships
using the ‘coin’ package in R [28]. Student’s t-tests with
Welch’s corrections were used to examine differences in
resource use phenotypes between Streptomyces with an-
tagonistic or resistant phenotypes and their non-
antagonistic or resistant counterparts for each individual
standard tested. Because antibiotic inhibitory phenotypes
among Streptomyces fell into two distinct categories, those
that did not inhibit any standards (non-inhibitors, n =109) and those that inhibited all 10 standards (super-
killers, n = 38), Student’s t-tests were used to compare dif-
ferences in resource use of Streptomyces among these cat-
egories. Similarly, although antibiotic resistance was
normally distributed, resource use among Streptomyces
with low (resisting 3–5 standards, n = 58) and high (resist-
ing 8–10 standards; n = 62) resistance capacities was also
compared using Student’s t-tests. Further, the ability of
Streptomyces belonging to high- versus low-inhibition or
resistance categories to utilize each of the n = 95 individ-
ual carbon sources was compared using Pearson’s Chi-
squared tests, where p-values <0.05 after adjustment for
multiple comparisons using an FDR correction were con-
sidered statistically significant.Results
Streptomyces inhibition and resistance
Streptomyces isolates varied in their abilities to inhibit
and resist standard strains, consistent with previous work
[4]. Patterns of inhibition were diverse: considering
discrete inhibitory phenotypes (+/−) there were 57 unique
inhibition profiles among the 263 isolates. Overall, individ-
ual Streptomyces inhibited an average of 3.1 standards,
though this average increased to 5.3 standards when con-
sidering only Streptomyces that could inhibit at least one
standard. However, most isolates had either very little or
very high inhibitory capacity, as reflected in the distinct bi-
modal distribution of isolate frequencies (Fig. 1a). The ma-
jority of Streptomyces either lacked any inhibitory capacity
(41 % of isolates did not inhibit any standard; Fig. 1a) or
had extremely broad inhibitory phenotypes (14 % of iso-
lates inhibited all 10 standards; Fig. 1a).
Resistance phenotypes among Streptomyces were less
diverse than inhibition phenotypes. Among 263 isolates
there were 29 unique resistance profiles. Streptomyces
isolates resisted 6.8 standards on average (Fig. 1b). Re-
sistance to inhibition by multiple standards was com-
mon among soil-borne Streptomyces. Every standard
inhibited at least two Streptomyces isolates, verifying that
each standard had some inhibitory capacity. Although
every Streptomyces isolate resisted inhibition by at least
three standards, only a small proportion (5 %) of isolates
was resistant to all ten standards. In contrast to the
bimodal distribution of inhibitory phenotypes, fre-
quencies of resistance were approximately normally
distributed among isolates and fell around a distinct
mode (median = 7, mode = 7).
Streptomyces capacities to inhibit and resist standards
were weakly correlated. There was a marginally signifi-
cant positive correlation between the number of stan-
dards inhibited and the number of standards resisted
among individual Streptomyces (Spearman’s ρ = 0.15, p =
0.012, z = 2.49), suggesting that Streptomyces with broad
Fig. 1 Frequency distribution of cumulative antibiotic inhibition (upper
panel) and resistance (lower panel) phenotypes of Streptomyces against
standard test isolates
Table 1 Differences in growth efficiency and niche widths among S
standards
Standard
Growth Efficiency (± SD)
Inhibitor Non-Inhibitor df t-val p-
LK2-12 0.067 ± 0.015 0.066 ± 0.016 158.1 0.52 0.6
LK4-2 0.062 ± 0.012 0.068 ± 0.016 117.7 −3.17 0.0
LK4-16 0.068 ± 0.017 0.066 ± 0.015 84.4 0.58 0.5
LK4-20 0.066 ± 0.016 0.067 ± 0.015 132.6 −0.34 0.7
LK4-21 0.065 ± 0.015 0.067 ± 0.015 114.1 −0.69 0.4
LK4-24 0.066 ± 0.015 0.067 ± 0.015 149.4 −0.51 0.6
LK6-14 0.063 ± 0.012 0.068 ± 0.016 158.2 −2.45 0.0
LK10-3 0.063 ± 0.012 0.068 ± 0.016 144.3 −2.40 0.0
DL87 0.063 ± 0.014 0.068 ± 0.016 209.4 −2.65 0.0
DL93 0.067 ± 0.016 0.066 ± 0.015 87.7 0.25 0.8
Growth efficiency (±standard deviation) and niche width (±standard deviation) of in
Degrees of freedom, t-values, and p-values of t-tests between inhibitory and non-in
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have broad resistance capacities.
Inhibition-resource use tradeoffs
Streptomyces with the ability to inhibit specific standards
versus those with no apparent inhibitory capacity against
that standard sometimes differed in growth efficiency or
niche width (Table 1). Inhibitors of standards LK4-2,
LK6-14, LK10-3, and DL87 had significantly smaller
growth efficiencies than isolates unable to inhibit each of
these standards. Similarly, inhibitors of standards LK4-2,
LK4-21, LK6-14, LK10-3, and DL87 had significantly
smaller niche widths than non-inhibitors. Overall, Strep-
tomyces able to inhibit specific standards consistently
had smaller niche widths than non-inhibitors against
those standards (ten of ten standards), though differ-
ences were only significant for four of the ten standards.
These results suggest that having inhibitory capacity to-
wards a standard sometimes comes at a cost with re-
spect to growth efficiency or niche width, though costs
may vary among antibiotics.
Among Streptomyces that exhibited inhibitory capaci-
ties against particular standards, there were significant
negative relationships between inhibition intensity (in-
hibition zone size) and growth efficiency for eight of ten
standards (Fig. 2). Among isolates that could inhibit a
given standard, inhibition zone size explained from 6 to
19 % of the variation in growth efficiency. This suggests
that Streptomyces with stronger inhibitory capacities are
less growth efficient, consistent with the idea that produ-
cing greater quantities of antibiotic imposes a cost in
growth efficiency. Further, variation in the slopes of rela-
tionships between inhibition intensity and growth effi-
ciency (Additional file 1) suggests that the costs of
increased inhibition, or antibiotic production, vary amongtreptomyces inhibitory and non-inhibitory towards individual
Niche Width (± SD)
val Inhibitor Non-Inhibitor df t-val p-val
05 70.5 ± 16.9 74.0 ± 16.2 140.9 −1.55 0.123
02 67.1 ± 18.2 74.7 ± 15.5 82.5 −2.89 0.005
62 69.9 ± 18.0 74.1 ± 15.9 84.8 −1.63 0.108
37 71.9 ± 16.3 74.1 ± 16.1 133.4 −0.99 0.325
90 70.0 ± 17.4 74.3 ± 16.1 106.6 −1.77 0.080
14 71.0 ± 16.9 74.0 ± 16.2 142.7 −1.31 0.191
16 68.7 ± 16.8 74.7 ± 16.1 116.3 −2.59 0.011
18 68.6 ± 16.5 74.5 ± 16.2 108.8 −2.50 0.014
09 67.4 ± 17.3 76.2 ± 15.0 161.1 −4.09 <0.001
06 70.1 ± 18.0 73.8 ± 16.0 83.1 −1.38 0.170
hibitory and non-inhibitory Streptomyces against individual standard isolates.
hibitory Streptomyces are presented
Fig. 2 Linear regression of growth efficiency and inhibition zone sizes among inhibitors of each of the 10 standard isolates
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tensity and niche width were also consistently negative,
though statistically significant for only 5 of the 10 stan-
dards (Additional file 1).
Considering cumulative inhibitory capacity, or the
total number of standards that a Streptomyces isolate
could inhibit rather than the inhibition zone size against
a given standard, the number of standards that an isolate
inhibited was weakly but significantly negatively corre-
lated with niche width (Fig. 3; Spearman’s ρ = −0.16, p =
0.008, z = −2.64), but not growth efficiency (Fig. 3; Spear-
man’s ρ = 0.008, p = 0.90, z = 0.13). Thus, isolates that
inhibited a larger number of standards had smaller niche
widths than those that inhibited fewer standards. How-
ever, correlations between total number of standards
inhibited and niche width were weak, perhaps due to the
variation in the costs of producing diverse antibiotics
and inhibiting different standards. Notably, non-inhibitory
isolates (inhibited none of the standards) and highly in-
hibitory ‘super-killers’ (inhibited all 10 standards) differed
significantly in resource use. Super-killer Streptomyces had
significantly smaller niche widths and grew less efficiently
than non-inhibitors (Fig. 4). Non-inhibitory Streptomyces
had on average 12.7 % larger niche widths (t-test, t = 2.77,
p = 0.007) and 6.8 % more efficient growth (t-test, t = 2.01,
p = 0.05) than super-killers. Thus, super-killers with broad
inhibitory capacities had more restricted niches and grew
less efficiently than non-inhibitory Streptomyces. This sug-
gests that there may be significant tradeoffs between cu-
mulative inhibition capacity and both niche width and
growth efficiency among Streptomyces. Niche width re-
ductions in super-killers may result from evolutionary tra-
deoffs between genomic investments in primary versusFig. 3 Relationships between cumulative inhibition (left panels) and resistan
efficiency (bottom panels) among Streptomyces isolates. Spearman’s correlat
panel. Bars represent mean growth efficiency or niche width in each categsecondary metabolism, specifically reductions in the diver-
sity of metabolic capacities retained by highly inhibitory
populations. In contrast, reduced growth efficiencies
among super-killers may be an ecological consequence of
energetic costs associated with antibiotic production that
limit population growth rates, rather than the diversity of
metabolic pathways.
Streptomyces with distinct inhibitory capacities (super-
killers versus non-inhibitors) differed in their likelihood
of using specific carbon sources for growth. Of the 95
sole carbon sources present on the Biolog SF-P2 plate,
21 carbon compounds were used significantly more
or less frequently by super-killers than non-inhibitory
Streptomyces (Fig. 5a). These differentially used carbon
sources included carbohydrates (n = 13), carboxylic acids
(n = 3), amino acids (n = 2), polymers (n = 1), and miscel-
laneous compounds (n = 2). In general, super-killers used
carbon sources less frequently than non-inhibitory Strep-
tomyces (n = 19 of 21 differentially used sole carbon
sources), consistent with a niche width-inhibition capacity
tradeoff. However, D-alanine and α-ketoglutaric acid were
used at significantly higher frequencies among super-
killers than among non-inhibitory strains (71 % vs. 45 %
and 92 % vs. 66 %, respectively).
Resistance-resource use tradeoffs
Streptomyces that could resist inhibition by particular
standards were sometimes less growth efficient or had
smaller niche widths than isolates that were susceptible
to that Streptomyces (Table 2). Isolates able to resist
standards LK2-12, LK4-16, LK4-24, LK6-14, DL87, and
DL93 were significantly less growth efficient than iso-
lates that were susceptible to these standards. Similarly,ce (right panels) phenotypes with niche width (top panels) and growth
ion coefficients and p-values are presented for relationships in each
ory
Fig. 4 Niche width (±SEM; top panels) and growth efficiency (±SEM; bottom panels) among Streptomyces exhibiting distinct inhibition strategies
(non-inhibitory vs super-killers; left panels) and resistance strategies (low resistance vs high resistance; right panels). P-values represent Student’s
t-tests between groups in each panel
Fig. 5 Sole carbon sources present on the Biolog SF-P2 plate that were used significantly more or less frequently among non-inhibitory versus
super-killer Streptomyces (a) or those with low versus high resistance capacity (b). Significant differences in frequencies of carbon source use were
determined with Pearson’s Chi-squared tests and, p-values <0.05 after FDR correction were considered significant
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Table 2 Differences in growth efficiency and niche widths among Streptomyces susceptible and resistant to individual standards
Standard
Growth Efficiency (± SD) Niche Width (± SD)
Resistant Susceptible df t-val p-val Resistant Susceptible df t-val p-val
LK2-12 0.062 ± 0.013 0.068 ± 0.016 94.3 −2.40 0.018 72.6 ± 13.0 73.3 ± 17.2 104.1 −0.33 0.742
LK4-2 0.066 ± 0.015 0.068 ± 0.014 20.1 −0.39 0.701 72.8 ± 16.6 74.1 ± 15.5 20.1 −0.34 0.740
LK4-16 0.064 ± 0.014 0.079 ± 0.017 56.8 −5.85 <0.001 71.1 ± 16.8 81.9 ± 10.7 96.1 −5.47 <0.001
LK4-20 0.067 ± 0.015 0.059 ± 0.010 4.4 1.68 0.161 73.2 ± 16.5 72.0 ± 12.8 4.3 0.21 0.845
LK4-21 0.063 ± 0.013 0.067 ± 0.016 62.1 −1.66 0.103 73.3 ± 11.9 73.2 ± 17.2 75.3 0.04 0.965
LK4-24 0.063 ± 0.013 0.068 ± 0.016 130.5 −2.57 0.011 72.7 ± 12.7 73.3 ± 17.5 148.2 −0.32 0.748
LK6-14 0.066 ± 0.015 0.078 ± 0.006 3.6 −3.44 0.031 73.1 ± 16.5 76.8 ± 13.2 3.1 −0.54 0.625
LK10-3 0.066 ± 0.015 0.073 ± 0.009 3.3 −1.49 0.226 73.3 ± 16.5 75.5 ± 6.6 3.6 −0.65 0.555
DL87 0.066 ± 0.015 0.082 ± 0.003 1.5 −6.86 0.043 73.2 ± 16.4 67.5 ± 13.4 1.0 0.60 0.654
DL93 0.063 ± 0.013 0.081 ± 0.017 66.5 −7.03 <0.001 71.6 ± 16.3 80.9 ± 12.4 100.2 −4.51 <0.001
Growth efficiency (±standard deviation) and niche width (±standard deviation) of Streptomyces resistant and susceptible to inhibition by individual standard
isolates. Degrees of freedom, t-values, and p-values of t-tests between resistant and susceptible Streptomyces are presented
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and DL93 also had smaller niche widths than susceptible
Streptomyces. In general, Streptomyces resistant to individ-
ual standards were consistently less growth efficient (9 of
10 standards) or had smaller niche widths (7 of 10 stan-
dards) than Streptomyces susceptible to that standard.
In contrast to relationships for inhibition intensity, re-
sistance zones (inhibition zone size of standards Strepto-
myces against environmental isolates) had no clear
relationship with growth efficiency or niche width. This
suggests that the costs of resistance may be largely asso-
ciated with the presence of a resistant phenotype, rather
than the degree of resistance conferred. However, the
number of susceptible Streptomyces varied considerably
for individual standards (n = 2 to n = 213; Additional file
1), which may limit our ability to detect significant rela-
tionships in cases where there are very few susceptible
isolates.
The number of standards that Streptomyces isolates
could resist was negatively correlated with niche width
(Fig. 3; Spearman’s ρ = −0.26, p < 0.0001, z = −4.15) and
growth efficiency (Fig. 3; Spearman’s ρ = −0.35, p <
0.0001, z = −5.72). Streptomyces with greater resistance
capacity tended to have smaller niche widths and grow
less efficiently than more susceptible isolates. Streptomy-
ces with very high versus low antibiotic resistance cap-
acities also differed significantly in resource use. Isolates
with little resistance to inhibition by standards (those
that could resist inhibition by ≤5 standards) had signifi-
cantly larger niche widths and higher growth efficiency
than highly resistant Streptomyces (those that resisted in-
hibition by ≥8 standards; Fig. 4). On average, Streptomy-
ces with little resistance had 12.4 % larger niche widths
(t-test, t = 4.12, p < 0.0001), and 28.0 % greater growth
efficiency (t-test, t = 6.53, p < 0.0001) than Streptomyces
with a high number of resistances, suggesting substantialgrowth efficiency-resistance and niche width-resistance
tradeoffs among Streptomyces isolates. Tradeoffs be-
tween niche width and resistance capacity may reflect
distinct genomic investment in primary metabolism ver-
sus antibiotic resistance strategies, where highly resistant
isolates are less capable of metabolizing diverse carbon
sources. In contrast, growth efficiency-resistance trade-
offs may be a consequence of the direct physiological
costs of bearing multiple resistance traits that limit
population growth rates.
Streptomyces with low versus high capacities to resist in-
hibition by standards differed significantly in the fre-
quency with which they used specific carbon compounds
for growth. Of the 95 sole carbon sources present on Bio-
log SF-P2 plates, nineteen carbon sources were used at
different frequencies between Streptomyces with low ver-
sus high resistance capacities (Fig. 5b). Differentially used
carbon compounds included carbohydrates (n = 13), poly-
mers (n = 3), amino acids (n = 1), and miscellaneous com-
pounds (n = 2). Similar to patterns observed for super-
killers versus non-inhibitors, Streptomyces with low resist-
ance capacities utilized most carbon compounds at signifi-
cantly higher frequencies than those with high resistance
capacities (n = 18 of the 19 differentially used sole carbon
sources). Intriguingly, D-alanine was an exception and
was used for growth by a greater proportion of highly re-
sistant strains (82 % of strains) than those with low resist-
ance capacities (40 % of strains). Together, these data
indicate that reductions in niche width among Streptomy-
ces with high versus low resistance capacities are often
specific to individual carbon compounds.
Discussion
Most Streptomyces were characterized by one of two dis-
tinct inhibitory strategies, tending to be either non-
inhibitory, or highly inhibitory “super-killers”. Because
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among Streptomyces isolates [4, 29], the benefits of pro-
ducing a particular antibiotic may vary across communi-
ties. Specifically, since genes encoding resistance to
antibiotics are broadly distributed in natural soil habitats
[7, 16, 30], competitors may acquire resistance to a spe-
cific antibiotic and offset the benefits of antibiotic pro-
duction to the producing organism [6, 13]. However,
combinations of antibiotics, especially those with differ-
ent modes of action, can substantially reduce the likeli-
hood that any one competitor bears resistance to every
antibiotic and may slow the evolution of novel resis-
tances [31]. Indeed, selection for Streptomyces to pro-
duce antibiotic compounds that act synergistically is
thought to play a significant role in the evolution of
Streptomyces secondary metabolism [15]. Thus, accumu-
lating multiple synergistic or complementary pathways
for antibiotic production within individual Streptomyces
strains may confer substantial and potentially synergistic
fitness benefits to producers across time and space. As a
result, optimal strategies for an antagonistic lifestyle may
tend towards relatively high accumulation of antibiotic
inhibitory phenotypes (super-killers), as observed here.
Although antibiotic phenotypes are assumed to impose
costs of production [11–13] our explicit goal was not to
determine physiological costs of in vitro antibiotic pro-
duction but rather to document life-history tradeoffs
across a diverse collection of naturally-occurring Strepto-
myces isolates. Negative relationships between Strepto-
myces inhibitory phenotypes and niche width or growth
efficiency and the substantially smaller growth efficiencies
and niche widths for super-killer versus non-inhibitory
Streptomyces suggest significant growth-inhibition and
niche width-inhibition tradeoffs associated with these
traits. These tradeoffs may represent physiological costs of
constitutive antibiotic production, pleiotropic effects of
genes involved in primary or secondary metabolism, or
the costs of accumulating antibiotic biosynthetic pathways
for multiple antibiotic compounds.
Negative relationships between inhibition intensity
against standards and growth efficiency or niche width
were common, yet significant differences in growth effi-
ciency or niche width between inhibitors and non-
inhibitors were observed for only a few standards. This
suggests that the physiological costs of inhibition of a
single target may be more strongly associated with in-
hibition intensity, while genomic costs were more evi-
denced in cumulative inhibitory capacities. Physiological
tradeoffs associated with expressing a given biosynthetic
pathway for antibiotic production may be offset by
tightly-controlled regulation. This is frequently the case
among Streptomyces, where genes encoding the produc-
tion of many secondary metabolites have diverse and
highly complex regulatory mechanisms which oftenrequire very specific growth conditions, nutrient limita-
tion, and/or extra-cellular signals for expression [32–35].
In general, the biosynthesis of many antibiotic com-
pounds produced by Streptomyces occurs when nitrogen,
phosphorus, or carbon sources become limiting and the
process of morphological differentiation is triggered [23,
32]. Moreover, some specific carbon compounds, such
as N-acetyl-glucosamine, can have differential effects on
this process depending on resource availability [22]. Be-
cause of the complex and tightly-controlled nature of
antibiotic biosynthesis, the tradeoffs observed in this
work between inhibition intensity and growth efficiency
or niche width may be capturing only a small subset of
the potential antibiotic compounds produced by Strepto-
myces isolates. We observed growth efficiency and niche
width tradeoffs associated with individual resistance phe-
notypes only for a small number of standards, suggesting
that the cost of any specific resistance phenotype may be
very small. This may be due in part to compensatory
mutations, which are likely to minimize tradeoffs by rap-
idly alleviating the costs of antibiotic resistance [36, 37]
or a low cost of resistance mechanisms that require induc-
tion by antibiotic compounds [38]. However, the signifi-
cant negative correlation between accumulated resistance
capacities with growth efficiency and niche width, as well
as the substantial difference in growth efficiency and niche
width among highly resistant versus susceptible isolates,
suggests that costs of resistance can be substantial as mul-
tiple resistances accumulate. Although some resistance
mechanisms may provide resistance to a broad range of
antibiotic compounds with little or no additive cost (eg.
multi-drug efflux pumps), epistatic interactions between
distinct resistance mechanisms or resistance mutations
are also suggested to be crucial to the fitness costs of anti-
biotic resistance [39, 40]. Thus, the greater-than-additive
costs of multiple resistances are likely to be important
constraints to the accumulation of antibiotic resistances
within Streptomyces populations in soil.
In contrast to antibiotic inhibition, cumulative capaci-
ties to resist antibiotic inhibition (the number of stan-
dards that an isolate could resist) were approximately
normally distributed among Streptomyces, and resistance
to inhibition by an intermediate number of standards
was the most common phenotype among isolates. In
natural settings Streptomyces are commonly resistant to
many antibiotics, even in environments with no history
of antibiotic contamination from anthropogenic sources
[16, 30]. This suggests that species interactions in natural
populations contribute to the maintenance of multiple re-
sistance phenotypes. In particular, strong selection for re-
sistance is expected to result from the severe fitness
consequences of being susceptible to inhibition by antibi-
otics produced by competitors. However, reductions in
growth efficiency and niche width as antibiotic resistances
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ance capacities in Streptomyces isolates. These constraints
combined with the substantial fitness cost of lacking re-
sistance to antibiotic-producers may generate stabilizing
selection that favors Streptomyces with moderate resist-
ance capacities rather than those having very few or very
many antibiotic resistances.
Highly inhibitory super-killer and highly resistant Strep-
tomyces used many carbon sources at significantly lower
frequencies than non-inhibitory or poorly resistant Strep-
tomyces. This suggests that reductions in niche widths as-
sociated with these lifestyles are resource-specific (Fig. 5),
and that physiological or genomic costs of these life-styles
are reflected in more restricted primary metabolic capabil-
ities to utilize specific compounds for growth. In some
cases (eg. for D-alanine, an essential component of the
peptidoglycan layer of the bacterial cell wall), these com-
pounds may be have a specific physiological role in anti-
biotic resistance phenotypes [41].
Although we found compelling evidence for resource
use tradeoffs with antibiotic inhibition and cumulative
resistance capacity, there was substantial variability in
niche width and growth efficiency among Streptomyces
with different antibiotic inhibition and resistance pheno-
types. This may in part be due to the assumption that
Streptomyces isolates able to inhibit or resist many other
strains produce more antibiotic compounds or have a
greater number of antibiotic resistance factors. However,
the potential that for some Streptomyces a single anti-
biotic can inhibit multiple standards is likely to con-
found the relationship between cumulative inhibition
capacity and niche width or growth efficiency among
isolates. Furthermore, due to the complex regulation of
antibiotic production, the phenotypic assays in this work
likely captured only a subset of the inhibitory potential
of our isolates. Similarly, the effectiveness of distinct re-
sistance mechanisms for providing protection against
multiple standards in this work is not known. Diverse
mechanisms of antibiotic resistance (eg. efflux pumps,
mutation, influx decrease, antibiotic modification) may
confer resistance to multiple antibiotics, or may also im-
pose different fitness costs [37, 40]. In light of these con-
siderations, the substantial variation in niche width and
growth efficiency among Streptomyces with similar in-
hibition or resistance capacities is not surprising. Further
studies using population genomics tools to quantify the
specific secondary metabolic pathways, resistance fac-
tors, and primary metabolic capacities of these popu-
lations will address these issues and offer critical
insight into genomic and physiological tradeoffs
among Streptomyces.
Intriguingly, reductions in growth efficiency and niche
width were substantially smaller for Streptomyces with
super-killer versus non-inhibitory life-history strategiesthan for those with highly resistant versus susceptible
lifestyles. This suggests that it may be more costly to ac-
cumulate capacities to resist many antibiotics than to ac-
cumulate ability to inhibit (kill) many targets. This is a
particularly novel finding considering that the fitness
costs of antibiotic resistance in clinical settings are often
found to be small [42] and that the pathways responsible
for antibiotic biosynthesis require one or more large,
multi-domain enzymes (polyketide synthases and non-
ribosomal peptide synthases). Differences in costs of accu-
mulating antibiotic resistance and antibiotic production
pathways may contribute significantly to the dynamics of
antibiotic inhibition and resistance in natural communities
across the landscape.Conclusions
Our findings suggest that tradeoffs are likely to constrain
the evolution of extreme antibiotic inhibitory and resist-
ance phenotypes among natural populations of soil-
borne Streptomyces. Moreover, greater apparent costs of
accumulating multiple resistances versus inhibitory cap-
acities are surprising, and appear to generate different
distributions of these phenotypes among Streptomyces
isolates. Further work exploring the roles tradeoffs play
in the evolution of Streptomyces will be essential to elu-
cidating the forces that generate and maintain the vast
diversity of antibiotic inhibitory and resistance pheno-
types in soil communities.Additional file
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